(Q40725244)

23 September 2017

1 reference

title

Hypertension following kidney transplantation (English)

1 reference

23 September 2017

Curtis JJ

1

1 reference

23 September 2017

publication date

1 March 1994

1 reference

American Journal of Kidney Diseases

23 September 2017

published in

1 reference

23 September 2017

volume

23

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

471-475

1 reference

Post-transplant hypertension

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Risk factors for accelerated atherosclerosis in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Influence of cyclosporine on posttransplant blood pressure response

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Cyclosporine-induced renal dysfunction in human renal allograft recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Cyclosporine-induced hypertension in sheep. The role of thromboxanes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Effects of chronic cyclosporine administration on renal blood flow and intrarenal blood flow distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Cyclosporine-induced sympathetic activation and hypertension after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Episodic Hypertension Associated with Positive Renin Assays after Renal Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Hypertension and Renin in Human Renal Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Benefits of removal of native kidneys in hypertension after renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Effect of CsA on the expression of renin and angiotensin type 1 receptor genes in the rat kidney.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Cyclosporine induced nephrotoxicity and juxtaglomerular apparatus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Cyclosporine nephrotoxicity in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Cyclosporine A enhances renin secretion and production in isolated juxtaglomerular cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Suppression of plasma renin activity by cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Does the kind of immunosuppressive therapy influence plasma renin activity, aldosterone and vasopressin in patients with a kidney transplant?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Bilateral native nephrectomy improves renal isograft function in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Cyclosporin in therapeutic doses increases renal allograft vascular resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Effects of ciclosporin on plasma renin activity, catecholamines and prostaglandins in patients with idiopathic uveitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

The pathophysiology of Sandimmune (cyclosporine) in man and animals

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Role of endothelin in cyclosporine-induced glomerular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Cyclosporine-induced changes in glomerular filtration rate and urea excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Effects of nitrendipine on blood pressure and blood ciclosporin A level in patients with posttransplant hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Effects of Isradipine on Renal Function in Cydosporin-Treated Renal Transplanted Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Increased cyclosporine blood concentrations due to verapamil administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981015-8

7 January 2021

10.1016/S0272-6386(12)81015-8

Identifiers

DOI

1 reference

23 September 2017

1 reference